Bedoradrine (INNTooltip International Nonproprietary Name; developmental code names KUR-1246, MN-221) is a sympathomimetic and bronchodilator medication that was developed for the treatment of preterm labor, asthma, and chronic obstructive pulmonary disease (COPD) but was never marketed.

[1][2][3] It acts as an ultra-selective long-acting β2-adrenergic receptor agonist.

[1][2] The drug was intended for intravenous administration.

[1][2] This drug article relating to the cardiovascular system is a stub.

You can help Wikipedia by expanding it.